ASSERTIO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Assertio Holdings, Inc. and Encourages Investors to Contact the Firm
January 08, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against...
Assertio Holdings Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information
January 08, 2024 12:14 ET
|
Block & Leviton LLP
BOSTON, Jan. 08, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against Assertio Holdings, Inc. (NASDAQ: ASRT) for securities law violations. Investors who purchased shares and have...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 05, 2024 18:56 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company that acquires, commercializes and...
Assertio Holdings, Inc. Announces Leadership Transition
January 03, 2024 08:59 ET
|
Assertio Holdings, Inc.
Dan Peisert Stepping Down as CEO Board member Heather Mason Appointed Interim CEO LAKE FOREST, Ill., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the...
Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors
November 14, 2023 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company that acquires, commercializes and...
Assertio Reports Third Quarter 2023 Financial Results
November 08, 2023 16:01 ET
|
Assertio Holdings, Inc.
Closed Spectrum Acquisition on July 31, 2023, which diversifies and extends portfolio duration Cash balance at September 30, 2023 of $76.9 million Announces Management Updates LAKE FOREST, Ill., Nov....
Assertio Holdings, Inc. to Release Third Quarter 2023 Financial Results on November 8, 2023
November 02, 2023 12:06 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 06, 2023 16:30 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 25, 2023 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 08, 2023 16:45 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...